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Abstract
Introduction: Low sensitivity and specificity in traditional laboratory tests became insufficient for accurate 
diagnostics and initiation of proper treatment of patients infected with bacterial meningitis. High sensitivity C-
reactive protein (hsCRP) may be an appropriate supplement for rapid diagnosis of bacterial meningitis. The 
subject of our investigation was the determination of C- reactive protein in cerebrospinal fluid (CSF) during 
acute bacterial meningitis.
Methods: HsCRP was analysed by a sensitive immunoturbidimetric assay using the Dimension RxL analy-
ser (Siemens). Cerebrospinal fluid concentrations of C-reactive protein have been measured in 20 patients 
(age range,1 to 50 years) presenting with acute bacterial meningitis and also in a non-infected, non-inflamed 
control group (n=25).
Results: The accuracy and precision of the method proved to be satisfactory. Repeatability of serial sampling 
for hsCRP described by coefficient of variation were CV=2.1-4.5%. This assay hsCRP in cerebrospinal fluid 
demonstrates adequate performance characteristics for routine clinical use. Elevated levels of CRP were 
found in 95% patients with bacterial meningitis. The mean CRP value in 25 uninfected control group was 0.25 
mg/L (range 0.10-0.55). The mean CRP for patients with bacterial meningitis was 21.4 mg/L (range 0.40-100).
Conclusions: A sensitive assay for CRP in CSF would be an useful adjunct to conventional investigation of 
acute infective meningitis. © 2012 All rights reserved
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Introduction
OC-reactive protein (CRP) is the acute phase pro-
tein, historically one of first to be recognised. In-
traindividual variation is a major limitation of the 
assay when the assay is used for directing therapies. 
Intraindividual variations of the CRP levels are 
from 30% to 60% (1). Serial measurement maybe 
required to estimate true mean of CRP depending 
on the intended application in any specific indi-
vidual. CRP seems to increase as a result of the 
inflammatory process, most notably in response 
to pneumococcal (bacterial) infection, histolytic 
disease, and a variety of other disease states (2).
CRP is composed of five identical, non-glycosylat-
ed, subunits each comprised of single polypeptide 
chain of 206 amino acid residues with a molecular 
mass of 23.017 daltons. This characteristic struc-
ture places CRP in the family of petraxins-calcium 
binding proteins with immune defence properties 
found in all vertebrates and most invertebrates 
(3). CRP is synthesized in the liver as a result of 
induction by the interleukin-6 family of cytokines. 
At the peak of an acute phase response as much 
as 20 % of the liver protein synthetics maybe di-
rected towards this process. Extra-hepatic synthe-
sis makes no contribution to the serum levels. The 
normal synthetic rate is 1-10 mg/day, increasing to 
more than 1 gram/day in acute inflammation (4).
The functions of CRP include the detection, clear-
ing and elimination of apoptotic tissue cells and 
their products such as DNA, which can be toxic 
or allergenic. At the same time, CRP acts as a 
non-adaptive defense mechanism by opsoniz-
ing microorganisms for phagocytosis. CRP bind-
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ing occurs only during targeting of affected cells 
when the normal structure of the lipid dual layer 
has been disrupted, leading to exposure of in-
ternal phospholipids of the cell membrane (5).
Many disorders of the central nervous system 
(CNS) are accompanied by increased CRP con-
centration in the cerebrospinal fluid (CSF) (6). 
Examination of CSF specific proteins used mainly 
to detect increased permeability of the blood-
brain barrier. Several disorders of the CNS such 
as bacterial meningitis, multiple sclerosis and 
other CNS inflammatory diseases are associated 
with an increase in CRP concentration in CFS (7). 
Patients with symptoms of meningitis usually un-
dergo lumbar puncture and in most cases of bacte-
rial infections this provides a typical image. Howev-
er in the selected group with negative microscopic 
evidence of infection the CSF-CRP is a useful di-
agnostic adjunct (8). Several studies in adults and 
children of all ages show that an increased CRP 
level is highly suggestive of a bacterial etiology (9).
The subject of our investigation was the deter-
mination of C- reactive protein in cerebrospinal 
fluid (CSF) during acute bacterial meningitis.
Methods
Twenty patients in the age group of 1 to 50 years 
with clinical diagnosis of bacterial meningitis were, 
included in the study. The control group included 
25 non-infected subjects. A sample of cerebrospi-
nal fluid is collected during a procedure called 
lumbar puncture. All specimens for investigations 
were collected before introduction of antibiotics.
HsCRP was analyzed in unconcentrated CSF by 
a sensitive immunoturbidimetric assay using the 
Dimension RxL analyzer (Siemens) with calibra-
tors and internal controls provided by Simens and 
according to manufacturer’s recommendations. 
This is a latex immunoassay developed to accu-
rately and reproducibly measure hs CRP. When an 
antigen-antibody reaction occurs between CRP in 
a sample and anti-CRP antibody, which has been 
adsorbed to latex particles, agglutination occurs. 
This agglutination is detected as an absorbance 
change(572 nm), with the rate of change being pro-
portional to the quantity of hs CRP in the sample.
The procedure of the Siemens assay accuracy eval-
uation included duplicate calibrators determining 
as samples (Calibrators levels 0, 5, 10, 20, 40 mg/
L),while the accuracy of the method was calculat-
ed by linear and regression analyses. Three quality 
control materials were used for quality control. Pre-
cision was calculated by measuring quality control 
materials in 20 duplicate with a single analytical run. 
Statistical analyses were performed using Micro-
soft Office Excel program package 2003, for the 
function of arithmetic mean and standard devia-
tion. The correlation was analyzed by linear re-
gression test. Values of p < 0.05 were considered as 
statistically significant. 
Results
The results of the hsCRP assay in cerebrospinal 
fluid assay precision analyses are showed in table 1.
The coefficients of variation (CV%) values 
of the precision were 2.1-4.3 %. The results 
variation was greater at lower concentrations. 
The hsCRP assay accuracy results were presented 
in table 2.
The statistically significant correlation between 
labeled and measured hsCRP values was ob-
tained (r=0.99; p<0.001), presented by the fol-
lowing equation: y=0.98 x + 0.23 were y repre-
sented the measured hsCRP levels, and x labeled 
hsCRP levels. An intercept (0.23) presented 
the systemic error of the method, which was 
not statistically significant (p>0.05) and slope 
(0.97) was a percentage deviation of -3% (100% 
- 97% = 3%) and was non-significant (p>0.05)..
Sample Sample value (n)
mean value 
(mg/l) Sd (mg/l) Cv (%)
control 1 20 0.46 0.02 4.3
control 2 20 4.9 0.13 2.6
Control 3 20 11.3 0.24 2.1
Table 1.  precision of hsCrp 
Calibrators (mg/l) 0 5.0 10.0 20.0 40.0
measured values* (mg/l) 0.1 4.9 9.8 19.7 38.2
Table 2.  Accuracy of hsCrp assay on Dimension rxl
*mean of two measurements of calibrators as sample.
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We determined the minimum, maximum and 
mean value(s) hsCRP in cerebrospinal fluid and 
the results are showed in table 3.
Comparasion data for the group patients with bac-
terial meningitis (BM) and control subjects are 
presented in Figure 1. 
The mean CRP value in 25 uninfected control group 
was 0.25 mg/L (range 0.10-0.55). The mean CRP for 
patients with bacterial meningitis was 21.4 mg/L 
(range 0.40-100). Elevated levels of hsCRP were 
found in 95 % patients with bacterial meningitis.
Discussion
Biochemical markers for diseases of central ner-
vous system are glucose, lactate, total proteins and 
C-reactive protein. CRP is an acute phase reactant 
synthesized by the liver upon stimulation by pro-
inflammatory cytokines reflecting both the acute 
and chronic inflammatory states (10). Acute phase 
reactant changes reflect the presence and intensity 
of inflammation, and have been used as a clinical 
guide to diagnosis and therapeutic management. 
CRP has many pathophysiologic roles in the in-
flammatory process (11). A major function of 
CRP is its ability to bind phosphocholine and thus 
recognize some foreign pathogens as well as phos-
pholipid constituents of damaged cells. In bacterial 
meningitis the changes in CRP concentrations are 
not induced by living bacteria and leukocytes. The 
anaerobic brain metabolism contributes to the de-
velopment of increased CSF- CRP concentrations. 
The cytokinine-endothelium-leukocyte interac-
tion is maybe responsible for the disruption of 
the blood-brain barrier by opening intercellular 
junctions and permitting the passage of C-reac-
tive proteins into the subarachnoidal space (12). 
CSF-CRP has been reported to be one of the most reli-
able and early indices to differentiate bacterial from 
non-bacterial meningitis. It is also useful in moni-
toring the clinical course of the meningitis (13,14).
The analysis of CSF-CRP by latex agglutination is 
rapid and easy to perform. The limit of quantifi-
cation for hs CRP assay is 0.1 mg/L, which is ac-
ceptable for routine clinical use. The CV for the 
imprecision in this assay is not greater than 5 % 
at the lowest measurable concentration. The ob-
tained CV% values for precision were 2.1 - 4.3. The 
hsCRP assay in cerebrospinal fluid showed good 
accuracy. The obtained CV% values was in accor-
dance with the manufactures recommendation. 
Linearity was confirmed with calibration curve in 
5 points in concentration range from 0 to 40 mg/L. 
The CSF hsCRP concentration was significantly 
increased in patients with disease. During our 
investigation it was noticed that the minimum 
concentration for hsCRP in patients with clini-
cal diagnosis of bacterial meningitis was 0.40 
mg/L. Maximum concentrations of 100 mg/L and 
mean values of 21.4 mg/L was established during 
the study. The mean CRP value in 25 uninfected 
control group was 0.25 mg/L (range 0.10-0.55).
In the present study, CSF-hsCRP was positive in 
19 of 20 cases of bacterial meningitis giving it a 
sensitivity rate of 95 %. 
Conclusion
The hs CRP assay on the Dimensin RxL analyser 
demonstrates adequate performance characteris-
tics for routine clinical use. The elevated hs CRP 
concentration of CSF during bacterial meningi-
tis is caused by an increased permeability of the 
examines n
minimum 
value 
(mg/l)
maximum 
value 
(mg/l)
mean 
value 
(mg/l)
patients with 
clinical diagnosis 
of meningitis
20 0.40 100.0 21.4
Control group 25 0.10 0.55 0.25
Table 3.  values of the hsCrp in patients with acute infec-
tious meningitis
FIGURe 1.  Crp distribution in the examined groups 
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blood-brain barrier. The sensitivity determination 
of hs CRP in cerebrospinal fluid is 95% in case 
of infective bacterial meningitis. It is concluded 
that C-reactive protein in CSF is a useful addi-
tional test for diagnosis of bacterial meningitis.
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